Entecavir prophylaxis for hepatitis B virus reactivation in patients with CAR T-cell therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Entecavir prophylaxis for hepatitis B virus reactivation in patients with CAR T-cell therapy

Published:2020-07-23 Issue:4 Volume:136 Page:516-519
ISSN:0006-4971
Container-title:Blood
language:en
Short-container-title:

Author:

Cao Wenyue¹²,Wei Jia¹²^ORCID,Wang Na¹²,Xu Hao¹²,Xiao Min¹²,Huang Lifang¹²,Cao Yang¹²,Li Chunrui¹²,Xiao Yi¹²,Gu Chaojiang³⁴,Zhang Shangkun⁴,Li Dengju¹²,Zhang Yichen¹²,Zhang Tongcun³⁴,Zhou Jianfeng¹²,Huang Liang¹²^ORCID

Affiliation:

1. Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei China;

2. Immunotherapy Research Center for Hematologic Diseases of Hubei Province, Wuhan, Hubei, China;

3. College of Life Science and Health, Wuhan University of Science and Technology, Wuhan, Hubei, China; and

4. Wuhan Bio-Raid Biotechnology Co., Ltd., Wuhan, Hubei, China

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

http://ashpublications.org/blood/article-pdf/136/4/516/1749025/bloodbld2020004907.pdf

Reference25 articles.

1. Hepatitis B virus reactivation in lymphoma patients with prior resolved hepatitis B undergoing anticancer therapy with or without rituximab;Yeo;J Clin Oncol,2009

2. Hepatitis B reactivation in patients with previous hepatitis B virus exposure undergoing rituximab-containing chemotherapy for lymphoma: a prospective study;Seto;J Clin Oncol,2014

3. Risk of hepatitis B virus reactivation in patients who are hepatitis B surface antigen negative/antibody to hepatitis B core antigen positive and the role of routine antiviral prophylaxis;Koo;J Clin Oncol,2009

4. Screening for and management of hepatitis B virus reactivation in patients treated with anti-B-cell therapy;Kusumoto;Hematology Am Soc Hematol Educ Program,2014

5. Hepatitis B virus reactivation in cancer patients with positive Hepatitis B surface antigen undergoing PD-1 inhibition;Zhang;J Immunother Cancer,2019

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evolution and diversity of the hepatitis B virus genome: Clinical implications;Virology;2024-10

2. How can we improve the successful identification of patients suitable for CAR-T cell therapy?;Expert Review of Molecular Diagnostics;2024-09-11

3. Post-Chimeric Antigen Receptor T-Cell Therapy Hepatitis B Virus Reactivation After 23 Months of Entecavir Prophylaxis;ACG Case Reports Journal;2024-09

4. What is the benefit of prophylaxis to prevent HBV reactivation in HBsAg‐negative anti‐HBc‐positive patients? Meta‐analysis and decision curve analysis;Liver International;2024-08-29

5. CAR-T therapy demonstrated safety and efficacy in relapsed/refractory diffuse large B-cell lymphoma patients complicated with hepatitis B related cirrhosis;2024-08-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3